Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death

Abstract excerpt

The quest for targeted therapies is critical in the battle against cancer. The RAS/MAP kinase pathway is frequently implicated in neoplasia, with ERK playing a crucial role as the most distal kinase in the RAS signaling cascade. Our previous research demonstrated that the interaction between ERK and MYD88, an adaptor protein in innate immunity, is crucial for RAS-dependent transformation and cancer cell survival....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Drug Discovery Methods
• Share to Cytokine Signaling Pathways and Interactions
• Share to Melanoma and MAPK Pathways